Advances in Public Health / 2018 / Article / Tab 2 / Research Article
High Baseline CD4 Count and Exclusive Breastfeeding Are Associated with Lower Rates of Mother to Child HIV Transmission in Northwestern Uganda: A Two-Year Retrospective Cohort Study Table 2 Bivariate analysis of factors associated with MTCT at ARRH, Northwestern Uganda.
Variable MTCT along the EID cascade? Total Univariable logistic regression analysis -value No (No., %) Yes (No., %) UOR (95% CI) Overall 270 (91.5) 25 (8.5) 295 Maternal age (years) Less or equals 30 53 (85.5) 9 (14.5) 62 Ref More than 30 217 (93.1) 16 (6.9) 233 0.43 (0.18–1.04) 0.060 Parity (children ever born) One 131 (92.2) 11 (7.8) 142 Ref More than one 139 (90.8) 14 (9.2) 153 0.20 (0.52–2.74) 0.666 Attended ANC during pregnancy No 107 (85.6) 18 (14.4) 125 Ref Yes 163 (95.9) 7 (4.1) 170 0.25 (0.10–0.63) 0.003 Baseline WHO Clinical staging I & II 232 (92.4) 19 (7.6) 251 Ref III & IV 38 (86.4) 6 (13.6) 44 1.93 (0.72–5.14) 0.189 Baseline CD4 count (cells/ml) <350 65 (83.3) 13 (16.7) 78 Ref 350–500 45 (95.7) 2 (4.3) 47 0.22 (0.05–1.03) 0.055 >500 160 (94.1) 10 (5.9) 170 0.312 (0.13–0.75) 0.009 Place of delivery Health facility 192 (94.1) 12 (5.9) 204 Ref Home 78 (85.7) 13 (14.3) 91 2.67 (1.16–6.10) 0.02 Mode delivery SVD 233 (92.8) 18 (7.2) 251 Ref Caesarean section 37 (84.1) 7 (15.9) 44 2.45 (0.96–6.26) 0.062 Nevirapine initiation after delivery Never at all 22 (62.9) 13 (37.1) 35 Ref After 6-weeks 3 (100.0) 0 (0.0) 3 1 From birth up to 6-weeks 245 (95.3) 12 (4.7) 257 0.08 (0.03–0.20) <0.001 Exclusive breastfeeding in first 6-months No 33 (66.0) 17 (34.0) 50 Ref Yes 237 (96.7) 8 (3.3) 245 0.06 (0.03–0.16) <0.001 Maternal use of ART ART naïve 5 (62.5) 3 (37.5) 8 Ref Received ART during labor and delivery 6 (54.6) 5 (45.4) 11 1.39 (0.22–8.92) 0.729 On life-long ART 259 (93.8) 17 (6.2) 276 0.11 (0.02–0.50) 0.004
Note . Percentages calculated as row percentages (n/N); ANC: antenatal care; AOR: adjusted odds ratio; ART: antiretroviral therapy; MTCT: mother to child transmission of HIV; NVP: Nevirapine; UOR: unadjusted odds ratio; Ref: reference category.